PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807421
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807421
U.S. Allergy and Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Products & Services (Allergy Diagnostics, Autoimmune Disease Diagnostics), By Test Type, By Diagnostics Type, By End Use - Market Forecast, 2025-2034
The U.S. allergy and autoimmune disease diagnostics market size is expected to reach USD 9.56 billion by 2034, according to a new study by Polaris Market Research. The report "U.S. Allergy and Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report By Products & Services (Allergy Diagnostics, Autoimmune Disease Diagnostics), By Test Type, By Diagnostics Type, By End Use - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The U.S. market for allergy and autoimmune disease diagnostics involves a range of tests and services. These are designed to identify and monitor conditions where the immune system is not working correctly. This includes allergies, which are an overreaction to harmless things in the environment, and autoimmune diseases, where the immune system attacks the body's own healthy tissues. The products in this market can be as simple as blood tests or as advanced as genetic sequencing.
The U.S. allergy and autoimmune disease diagnostics market is highly competitive. Companies are trying to create more accurate and effective diagnostic tools. The goal is to provide fast and reliable results that help doctors make the right decisions about a patient's care. The overall market is seeing growth owing to the high prevalence of these conditions, a greater focus on early diagnosis, and ongoing improvements in testing technology.
U.S. Allergy and Autoimmune Disease Diagnostics Market Report Highlights:
Based on product & services, the allergy diagnostics segment held the largest share in 2024. due to the increasing prevalence of conditions such as asthma, allergic rhinitis, and food allergies.
Based on test type, the allergy diagnostics segment held the largest share in 2024. due to the wide use of diagnostic tests that identify common allergens.
Based on diagnostics type, the allergy diagnostics segment held the largest share in 2024, as there is a rise in public awareness and a growing requirement for allergy identification.
Based on end use, the allergy diagnostics segment held the largest share in 2024, due to their large patient volumes and access to advanced equipment.
A few key players in the U.S. allergy and autoimmune disease diagnostics market include Abbott Laboratories, Bio-Rad Laboratories, Quest Diagnostics, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific (Phadia AB), and Grifols S.A. Other companies like bioMerieux SA, Trinity Biotech plc, Werfen, and EUROIMMUN Medizinische Labordiagnostika AG.
Polaris Market Research has segmented the U.S. allergy and autoimmune disease diagnostics market report based on products & services, test type, diagnostics type, and end use:
By Products & Services Outlook (Revenue - USD Billion, 2020-2034)
Allergy Diagnostics
Instruments
Consumables
Services
Autoimmune Disease Diagnostics
Instruments
Consumables
Services
By Test Type Outlook (Revenue - USD Billion, 2020-2034)
Allergy Diagnostics
In vivo Test
Skin Prick Test
Intradermal Test
Patch Test
In vitro Test
Autoimmune Disease Diagnostics
Antinuclear Antibody Tests
Autoantibody Tests
C-reactive Protein (CRP)
Complete Blood Count (CBC)
Urinalysis
Others
By Diagnostics Type Outlook (Revenue - USD Billion, 2020-2034)
Allergy Diagnostics
Food
Dairy Products
Poultry Product
Tree Nuts
Peanuts
Shellfish
Wheat
Soys
Other Food Allergens
Inhaled
Drug
Other Allergens
Autoimmune Disease Diagnostics
Systemic Autoimmune Disease Diagnostics
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others
Localized Autoimmune Disease Diagnostics
Multiple Sclerosis
Type 1 Diabetes
Hashimoto's Thyroiditis
Idiopathic Thrombocytopenic Purpura
Others
By End Use Outlook (Revenue - USD Billion, 2020-2034)
Allergy Diagnostics
Hospitals & Clinics
Diagnostics Laboratories
Research Institutions
Others
Autoimmune Disease
Hospitals & Clinics
Diagnostics Laboratories
Research Institutions
Others
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. U.S. Allergy and Autoimmune Disease Diagnostics Market Insights
- 4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market - Market Snapshot
- 4.2. U.S. Allergy and Autoimmune Disease Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Allergic and Autoimmune Diseases
- 4.2.1.2. Technological Advancements in Diagnostics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of diagnostic tests and limited reimbursement
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Allergy and Autoimmune Disease Diagnostics Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services, 2020-2034 (USD Billion)
- 5.3. Allergy Diagnostics
- 5.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020-2034 (USD Billion)
- 5.3.2. Instruments
- 5.3.3. Consumables
- 5.3.4. Services
- 5.4. Autoimmune Disease Diagnostics
- 5.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD Billion)
- 5.4.2. Instruments
- 5.4.3. Consumables
- 5.4.4. Services
6. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 6.3. Allergy Diagnostics
- 6.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020-2034 (USD Billion)
- 6.3.2. In vivo Test
- 6.3.2.1. Skin Prick Test
- 6.3.2.2. Intradermal Test
- 6.3.2.3. Patch Test
- 6.3.3. In vitro Test
- 6.4. Autoimmune Disease Diagnostics
- 6.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD Billion)
- 6.4.2. Antinuclear Antibody Tests
- 6.4.3. Autoantibody Tests
- 6.4.4. C-reactive Protein (CRP)
- 6.4.5. Complete Blood Count (CBC)
- 6.4.6. Urinalysis
- 6.4.7. Others
7. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2020-2034 (USD Billion)
- 7.3. Allergy Diagnostics
- 7.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020-2034 (USD Billion)
- 7.3.2. Food
- 7.3.2.1. Dairy Products
- 7.3.2.2. Poultry Product
- 7.3.2.3. Tree Nuts
- 7.3.2.4. Peanuts
- 7.3.2.5. Shellfish
- 7.3.2.6. Wheat
- 7.3.2.7. Soys
- 7.3.2.8. Other Food Allergens
- 7.3.3. Inhaled
- 7.3.4. Drug
- 7.3.5. Other Allergens
- 7.4. Autoimmune Disease Diagnostics
- 7.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD Billion)
- 7.4.2. Systemic Autoimmune Disease Diagnostics
- 7.4.2.1. Rheumatoid Arthritis
- 7.4.2.2. Ankylosing Spondylitis
- 7.4.2.3. Systemic Lupus Erythematosus (SLE)
- 7.4.2.4. Others
- 7.4.3. Localized Autoimmune Disease Diagnostics
- 7.4.3.1. Multiple Sclerosis
- 7.4.3.2. Type 1 Diabetes
- 7.4.3.3. Hashimoto's Thyroiditis
- 7.4.3.4. Idiopathic Thrombocytopenic Purpura
- 7.4.3.5. Others
8. U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Allergy Diagnostics
- 8.3.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Allergy Diagnostics, by Region, 2020-2034 (USD Billion)
- 8.3.2. Hospitals & Clinics
- 8.3.3. Diagnostics Laboratories
- 8.3.4. Research Institutions
- 8.3.5. Others
- 8.4. Autoimmune Disease
- 8.4.1. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Autoimmune Disease, by Region, 2020-2034 (USD Billion)
- 8.4.2. Hospitals & Clinics
- 8.4.3. Diagnostics Laboratories
- 8.4.4. Research Institutions
- 8.4.5. Others
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bio-Rad Laboratories
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. bioMerieux SA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. EUROIMMUN Medizinische Labordiagnostika AG (Revvity, Inc.)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Grifols S.A.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Quest Diagnostics
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Siemens Healthineers AG
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Thermo Fisher Scientific Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Trinity Biotech plc
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Werfen
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
List of Tables:
- Table 1 U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services, 2020-2034 (USD Billion)
- Table 2 U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- Table 3 U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2020-2034 (USD Billion)
- Table 4 U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. U.S. Allergy and Autoimmune Disease Diagnostics Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Products & Services
- Figure 7. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Products & Services, 2024 & 2034 (USD Billion)
- Figure 8. Market by Test Type
- Figure 9. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Test Type, 2024 & 2034 (USD Billion)
- Figure 10. Market by Diagnostics Type
- Figure 11. U.S. Allergy and Autoimmune Disease Diagnostics Market, by Diagnostics Type, 2024 & 2034 (USD Billion)
- Figure 12. Market by End Use
- Figure 13. U.S. Allergy and Autoimmune Disease Diagnostics Market, by End Use, 2024 & 2034 (USD Billion)
